These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26242711)

  • 21. Insulin resistance and the metabolic syndrome in obese French children.
    Druet C; Dabbas M; Baltakse V; Payen C; Jouret B; Baud C; Chevenne D; Ricour C; Tauber M; Polak M; Alberti C; Levy-Marchal C
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):672-8. PubMed ID: 16712670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and the obesity paradox in heart failure.
    Gupta PP; Fonarow GC; Horwich TB
    Can J Cardiol; 2015 Feb; 31(2):195-202. PubMed ID: 25661554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery disease and prevention of heart failure.
    Klein L; Gheorghiade M
    Med Clin North Am; 2004 Sep; 88(5):1209-35. PubMed ID: 15331314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic syndrome as a risk factor for venous and arterial thrombosis.
    Dentali F; Squizzato A; Ageno W
    Semin Thromb Hemost; 2009 Jul; 35(5):451-7. PubMed ID: 19739035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Profile of the main risk factors of arteriosclerosis in patients with diabetes mellitus].
    Tatoń J; Walewski J
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):3-7. PubMed ID: 1409038
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of the metabolic syndrome and its components combinations on arterial stiffness in Type 2 diabetic men.
    Levisianou D; Melidonis A; Adamopoulou E; Skopelitis E; Koutsovasilis A; Protopsaltis I; Zairis M; Kougialis S; Skoularigis I; Koukoulis G; Foussas S; Triposkiadis F
    Int Angiol; 2009 Dec; 28(6):490-5. PubMed ID: 20087288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome and heart failure--the risk, paradox, and treatment.
    Gaddam KK; Ventura HO; Lavie CJ
    Curr Hypertens Rep; 2011 Apr; 13(2):142-8. PubMed ID: 21298579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation.
    Sui W; Zou H; Zou G; Yan Q; Chen H; Che W; Xie S
    Transpl Immunol; 2008 Nov; 20(1-2):95-8. PubMed ID: 18703143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolic syndrome--from insulin resistance to obesity and diabetes.
    Gallagher EJ; Leroith D; Karnieli E
    Med Clin North Am; 2011 Sep; 95(5):855-73. PubMed ID: 21855696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome.
    Kono M; Tatsumi K; Saibara T; Nakamura A; Tanabe N; Takiguchi Y; Kuriyama T
    Chest; 2007 May; 131(5):1387-92. PubMed ID: 17494788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The illusion of prostate-specific antigen decline in patients with metabolic syndrome and insulin resistance.
    Choi HC; Park JH; Cho BL; Son KY; Yoo YJ; Kwon HT
    BJU Int; 2011 Dec; 108(11):1756-61. PubMed ID: 21507191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.
    Lavie CJ; Alpert MA; Arena R; Mehra MR; Milani RV; Ventura HO
    JACC Heart Fail; 2013 Apr; 1(2):93-102. PubMed ID: 24621833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sweet heart - contributions of metabolism in the development of heart failure in diabetes mellitus.
    Stratmann B; Tschoepe D
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S40-5. PubMed ID: 18777453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome and its association with colorectal cancer: a review.
    Siddiqui AA
    Am J Med Sci; 2011 Mar; 341(3):227-31. PubMed ID: 20460980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose Metabolism Abnormalities in Heart Failure Patients: Insights and Prognostic Relevance.
    Marsico F; Gargiulo P; Marra AM; Parente A; Paolillo S
    Heart Fail Clin; 2019 Jul; 15(3):333-340. PubMed ID: 31079691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic syndrome as a coronary risk factor. Prevention and treatment].
    Kłosiewicz-Latoszek L; Cybulska B
    Kardiol Pol; 2003 Jul; 59(7):59-65. PubMed ID: 14560351
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.